Rhythm Pharmaceuticals (RYTM) had the highest return between July 1, 2022 and January 1, 2023 by a mid-cap US stock, returning 613.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Rhythm Pharmaceuticals (RYTM) | 7/1/2022 - 1/1/2023 | 613.73% |
Verona Pharma PLC ADR (VRNA) | 7/1/2022 - 1/1/2023 | 531.16% |
Akero Therapeutics (AKRO) | 7/1/2022 - 1/1/2023 | 466.12% |
Immunovant (IMVT) | 7/1/2022 - 1/1/2023 | 352.81% |
Madrigal Pharmaceuticals (MDGL) | 7/1/2022 - 1/1/2023 | 303.85% |
Viking Therapeutics (VKTX) | 7/1/2022 - 1/1/2023 | 226.39% |
TG Therapeutics (TGTX) | 7/1/2022 - 1/1/2023 | 179.67% |
Catalyst Pharmaceuticals (CPRX) | 7/1/2022 - 1/1/2023 | 166.09% |
Weatherford International (WFRD) | 7/1/2022 - 1/1/2023 | 140.3% |
Torm PLC Class A (TRMD) | 7/1/2022 - 1/1/2023 | 140.16% |
Biohaven Pharmaceutical (BHVN) | 7/1/2022 - 1/1/2023 | 131.33% |
Transportadora de Gas del Sur SA ADR (TGS) | 7/1/2022 - 1/1/2023 | 130.92% |
Crocs (CROX) | 7/1/2022 - 1/1/2023 | 124.45% |
Nuvalent (NUVL) | 7/1/2022 - 1/1/2023 | 119.78% |
Vista Oil Gas ADR (VIST) | 7/1/2022 - 1/1/2023 | 110.48% |
Manchester United (MANU) | 7/1/2022 - 1/1/2023 | 109.8% |
Extreme Networks (EXTR) | 7/1/2022 - 1/1/2023 | 107.36% |
Enel Chile SA ADR (ENIC) | 7/1/2022 - 1/1/2023 | 104.54% |
Axsome Therapeutics (AXSM) | 7/1/2022 - 1/1/2023 | 102.55% |
Calix (CALX) | 7/1/2022 - 1/1/2023 | 102.52% |
Melco Resorts & Entertainment (MLCO) | 7/1/2022 - 1/1/2023 | 100.35% |
F&G Annuities & Life (FG) | 7/1/2022 - 1/1/2023 | 100.1% |
MoonLake Immunotherapeutics (MLTX) | 7/1/2022 - 1/1/2023 | 100% |
Roivant Sciences (ROIV) | 7/1/2022 - 1/1/2023 | 97.77% |
TransMedics (TMDX) | 7/1/2022 - 1/1/2023 | 96.69% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
